These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 15979415)
61. A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials. de Almeida DM; Fernandes-Pedrosa Mde F; de Andrade RM; Marcelino JR; Gondo-Higashi H; de Azevedo Ide L; Ho PL; van den Berg C; Tambourgi DV Am J Trop Med Hyg; 2008 Sep; 79(3):463-70. PubMed ID: 18784245 [TBL] [Abstract][Full Text] [Related]
62. Two new phospholipase D isoforms of Loxosceles laeta: cloning, heterologous expression, functional characterization, and potential biotechnological application. Catalán A; Cortes W; Sagua H; González J; Araya JE J Biochem Mol Toxicol; 2011; 25(6):393-403. PubMed ID: 21692149 [TBL] [Abstract][Full Text] [Related]
63. Loxosceles sphingomyelinase induces complement-dependent dermonecrosis, neutrophil infiltration, and endogenous gelatinase expression. Tambourgi DV; Paixão-Cavalcante D; Gonçalves de Andrade RM; Fernandes-Pedrosa Mde F; Magnoli FC; Paul Morgan B; van den Berg CW J Invest Dermatol; 2005 Apr; 124(4):725-31. PubMed ID: 15816830 [TBL] [Abstract][Full Text] [Related]
64. Inflammatory events induced by brown spider venom and its recombinant dermonecrotic toxin: a pharmacological investigation. Paludo KS; Biscaia SM; Chaim OM; Otuki MF; Naliwaiko K; Dombrowski PA; Franco CR; Veiga SS Comp Biochem Physiol C Toxicol Pharmacol; 2009 Apr; 149(3):323-33. PubMed ID: 19041422 [TBL] [Abstract][Full Text] [Related]
65. An inhibitor of complement in the venom of the brown recluse spider, Loxosceles reclusa. Kniker WT; Morgan PN; Flanigan WJ; Reagan PW; Dillaha CJ Proc Soc Exp Biol Med; 1969 Sep; 131(4):1432-4. PubMed ID: 5812012 [No Abstract] [Full Text] [Related]
66. Brown recluse spider bites: a complex problem wound. A brief review and case study. Wilson JR; Hagood CO; Prather ID Ostomy Wound Manage; 2005 Mar; 51(3):59-66. PubMed ID: 15984400 [TBL] [Abstract][Full Text] [Related]
67. Antigenic cross-reactivity of venoms from medically important North American Loxosceles spider species. Gomez HF; Miller MJ; Waggener MW; Lankford HA; Warren JS Toxicon; 2001 Jun; 39(6):817-24. PubMed ID: 11137541 [TBL] [Abstract][Full Text] [Related]
68. Sphingomyelinase D in sicariid spider venom is a potent insecticidal toxin. Zobel-Thropp PA; Kerins AE; Binford GJ Toxicon; 2012 Sep; 60(3):265-71. PubMed ID: 22561243 [TBL] [Abstract][Full Text] [Related]
69. Clinical consequences of spider bites: recent advances in our understanding. Isbister GK; White J Toxicon; 2004 Apr; 43(5):477-92. PubMed ID: 15066408 [TBL] [Abstract][Full Text] [Related]
71. Lysis of human erythrocytes by venom from the brown recluse spider, Loxosceles reclusa. Morgan BB; Morgan PN; Bowling RE Toxicon; 1978; 16(1):85-8. PubMed ID: 622732 [No Abstract] [Full Text] [Related]
72. Identification and neutralization of biological activities in the venoms of Loxosceles spiders. Barbaro KC; Ferreira ML; Cardoso DF; Eickstedt VR; Mota I Braz J Med Biol Res; 1996 Nov; 29(11):1491-7. PubMed ID: 9196551 [TBL] [Abstract][Full Text] [Related]
73. A Web of Coagulotoxicity: Failure of Antivenom to Neutralize the Destructive (Non-Clotting) Fibrinogenolytic Activity of Grashof D; Zdenek CN; Dobson JS; Youngman NJ; Coimbra F; Benard-Valle M; Alagon A; Fry BG Toxins (Basel); 2020 Jan; 12(2):. PubMed ID: 32019058 [TBL] [Abstract][Full Text] [Related]
74. Two successive necrotic lesions secondary to presumed loxosceles envenomation. Tarullo DB; Jacobsen RC; Algren DA Wilderness Environ Med; 2013 Jun; 24(2):132-5. PubMed ID: 23352313 [TBL] [Abstract][Full Text] [Related]
75. A reduced immunization scheme to obtain an experimental anti-Loxosceles laeta ("violinist spider") venom. de Roodt AR; Litwin S; Dokmetjian JC; Vidal JC J Nat Toxins; 2002 Aug; 11(3):193-203. PubMed ID: 12182539 [TBL] [Abstract][Full Text] [Related]
76. Brown spider phospholipase-D containing a conservative mutation (D233E) in the catalytic site: identification and functional characterization. Vuitika L; Gremski LH; Belisário-Ferrari MR; Chaves-Moreira D; Ferrer VP; Senff-Ribeiro A; Chaim OM; Veiga SS J Cell Biochem; 2013 Nov; 114(11):2479-92. PubMed ID: 23733617 [TBL] [Abstract][Full Text] [Related]
77. Comparative analyses of venoms from American and African Sicarius spiders that differ in sphingomyelinase D activity. Zobel-Thropp PA; Bodner MR; Binford GJ Toxicon; 2010 Jun; 55(7):1274-82. PubMed ID: 20144895 [TBL] [Abstract][Full Text] [Related]
78. Comparison of enzymatic activity from three species of necrotising arachnids in Australia: Loxosceles rufescens, Badumna insignis and Lampona cylindrata. Young AR; Pincus SJ Toxicon; 2001; 39(2-3):391-400. PubMed ID: 10978759 [TBL] [Abstract][Full Text] [Related]
79. Role of IgG(T) and IgGa isotypes obtained from arachnidic antivenom to neutralize toxic activities of Loxosceles gaucho, Phoneutria nigriventer and Tityus serrulatus venoms. Toro AF; Malta MB; Soares SL; Da Rocha GC; da Silva Lira M; De Oliveira TA; Takehara HA; Lopes-Ferreira M; Santoro ML; Guidolin R; Gondo Higashi H; Fernandes I; Barbaro KC Toxicon; 2006 Nov; 48(6):649-61. PubMed ID: 16979205 [TBL] [Abstract][Full Text] [Related]